Nephrology

Results of an extensive retrospective study indicate a strong association between glomerular filtration (eGFR) rate and cardiovascular disease morbidity rate.

A two-for-one deal: both cardiovascular benefits and renal protection.

Just one incident of DKA could potentially damage memory in children with type 1 diabetes.

A diabetes patient’s risk for chronic kidney disease or cardiovascular disease can be impacted by various factors, including ethnic background. 

Can use of the sodium-glucose cotransporter 1 and sodium-glucose cotransporter 2 dual inhibitor in patients with type 1 diabetes preserve kidney function?

Diabetes management can be a major factor in renal transplant aftercare; can DPP-4 therapy help improve outcomes?

A cohort study on the risk of major adverse kidney events for new patients initiated on empagliflozin versus other non-SGLT2I antihyperglycemics.

There is a potential role in using dapagliflozin in patients with CKD. 

How triple therapy can lead to optimal cardiovascular and renal protection. 

The EXSCEL trial may not have shown that once-weekly exenatide had cardiovascular benefits for patients with diabetes, but did show a benefit in some significant areas.